BX Swiss TOP 30 CHF
1.386,27
PKT
+7,48
PKT
+0,54
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.02.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 01.02.21 | Holcim Outperform | Credit Suisse Group | |
| 01.02.21 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 01.02.21 | Givaudan Hold | Deutsche Bank AG | |
| 01.02.21 | Givaudan Underperform | Bernstein Research | |
| 01.02.21 | Givaudan Underperform | Credit Suisse Group | |
| 29.01.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.01.21 | Givaudan add | Baader Bank | |
| 29.01.21 | Givaudan Underperform | Bernstein Research | |
| 28.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 28.01.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Givaudan buy | UBS AG | |
| 27.01.21 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 27.01.21 | Swiss Re Outperform | RBC Capital Markets | |
| 27.01.21 | UBS buy | Kepler Cheuvreux | |
| 27.01.21 | UBS buy | Goldman Sachs Group Inc. | |
| 27.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Novartis Neutral | Credit Suisse Group | |
| 27.01.21 | UBS Outperform | Credit Suisse Group | |
| 27.01.21 | UBS Underweight | Barclays Capital | |
| 26.01.21 | Roche buy | Goldman Sachs Group Inc. | |
| 26.01.21 | UBS Neutral | UBS AG | |
| 26.01.21 | Novartis buy | UBS AG | |
| 26.01.21 | Novartis overweight | Morgan Stanley | |
| 26.01.21 | UBS Equal-Weight | Morgan Stanley | |
| 26.01.21 | Novartis Hold | Kepler Cheuvreux | |
| 26.01.21 | UBS buy | Kepler Cheuvreux | |
| 26.01.21 | UBS Sector Perform | RBC Capital Markets | |
| 26.01.21 | UBS Neutral | Goldman Sachs Group Inc. | |
| 26.01.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.21 | UBS overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 25.01.21 | Roche Reduce | Oddo BHF | |
| 25.01.21 | Novartis Neutral | Oddo BHF | |
| 25.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.01.21 | Swiss Re Neutral | Credit Suisse Group | |
| 22.01.21 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.21 | Holcim overweight | Morgan Stanley | |
| 22.01.21 | Roche overweight | Barclays Capital | |
| 22.01.21 | Novartis Underweight | Barclays Capital |